Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease

Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease

Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients with ischemic heart disease (IHD) with chronic...

Full description

Bibliographic Details
Main Authors: Т A Fedorova, Yu V Ilyina, Т I Sotnikova, M К Rybakova, N V Loschits
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2004-03-01
Series:Терапевтический архив
Subjects:
ischemic heart disease
chronic heart failure
treatment
bisoprolol
trimetazidine
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/29796

Internet

https://ter-arkhiv.ru/0040-3660/article/view/29796

Similar Items